An EBV-Positive Lymphoproliferative Disorder after Therapy with Alemtuzumab
I. M. Ghobrial
and Others
- 25 Dec, 2003
This article requires a subscription.
Login via Athens or your institution
Already a print subscriber? Activate your online access
Not a Subscriber?
